CAR-T Cancer Therapy: Supercharging a Patient’s Own Cells to Battle Cancer
CAR-T Cancer Therapy: Supercharging a Patient’s Own Cells to Battle Cancer
The U.S. Food and Drug Administration has approved a novel cancer treatment that resulted in 83% of patients with resistant leukemia going into remission, and the majority remaining cancer free after a year. Contine reading